Crossmark

Clinical decisions surrounding genomic and proteomic testing among United States veterans treated for lung cancer within the Veterans Health Administration

Crossref DOI link: https://doi.org/10.1186/s12911-017-0475-8

Published Online: 2017-05-30

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Efimova, Olga

Berse, Brygida

Denhalter, Daniel W.

DuVall, Scott L.

Filipski, Kelly K.

Icardi, Michael

Kelley, Michael J.

Lynch, Julie A.
Funding

Funding for this research was provided by:

VA Informatics and Computing Infrastructure (VA HSR RES 13-457)

National Cancer Institute (Interagency Agreement 14001-0000-01001)
License Information

Text and Data Mining valid from 2017-05-30

Version of Record valid from 2017-05-30
More Information

Article History

Received: 21 December 2016

Accepted: 23 May 2017

First Online: 30 May 2017

Document is current

Any future updates will be listed below